Evidence map›Paper›PMID 39907959›Full record

ArticleEJNMMI physics2025

Discordance between

Thomas Carlier, Silvano Gnesin, Justin K Mikell, Maurizio Conti, John O Prior, Niklaus Schaefer, Maria Del Sol Pérez Lago, Clément Bailly, Yuni K Dewaraja, Thiago V M Lima

Abstract read
In one paragraph

Article in EJNMMI physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Evaluation of end-to-end 3D absorbed dose distribution inEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thomas CarlierNuclear Medicine Department, University Hospital of Nantes, Nantes, France.ORCID http://orcid.org/0000-0002-6932-7322
Silvano GnesinInstitute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-6547-3824
Justin K MikellDepartment of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-0679-7199
Maurizio ContiSiemens Medical Solutions, Knoxville, TN, USA.
John O PriorDepartment of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011, Lausanne, Switzerland. john.prior@chuv.ch.ORCID http://orcid.org/0000-0003-1429-1374
Niklaus SchaeferDepartment of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-9732-7696
Maria Del Sol Pérez LagoDepartment of Radiology and Nuclear Medicine, Luzerner Kantonsspital, Lucerne, Switzerland.ORCID http://orcid.org/0009-0001-1955-2716
Clément BaillyNuclear Medicine Department, University Hospital of Nantes, Nantes, France.ORCID http://orcid.org/0000-0001-8313-3287
Yuni K DewarajaDivision of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-3920-6925
Thiago V M LimaDepartment of Radiology and Nuclear Medicine, Luzerner Kantonsspital, Lucerne, Switzerland.ORCID http://orcid.org/0000-0002-3105-9270

Funding

Imaging and Dosimetry of Yttrium-90 for Personalized Cancer TreatmentR01EB022075 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DEWARAJA, YUNI K · 2016 to 2023
$4.7M
Agence Nationale de la Recherche ANR-21-RHUS-0012National Institute of Health (USA) NIH R01 EB02207NIBIB NIH HHS R01 EB022075
6 · The paper itself

Abstract

purposeTherapeutic administration of

methodsWe analysed patient

resultsQuantification ratio between calibrators and PET was significantly different from 1, regardless of the scatter correction used. In glass microspheres, the mean A

conclusionsWe observed in patients similar activity discrepancies as reported for vials, with a relative difference of 44 ± 16% between glass and resin

Indexed as

ActivityGlass microspheresPET/CTResin microspheresYttrium-90

Identifiers

PMID39907959
PMCPMC11799454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.